Because thymic dysfunction in establishing central self-tolerance to insulin-secreting islet β cells in the pancreas is central to T1D, novel therapies have explored negative/tolerogenic self-vaccinations to reprogram tolerance [114]. The gene discussed is INS; the disease is type 1 diabetes mellitus.